You are here


MSF - Doctors Without Borders - Ebola Guide

Ebola is one of the world’s most deadly diseases. It is a highly infectious virus that can kill up to 90 percent of the people who catch it, causing terror among infected communities.

Ebola is so infectious that patients need to be treated in isolation by staff wearing protective clothing. MSF has over 670 staff on the ground and we have brought in more than 40 tonnes of equipment and supplies to help fight the epidemic.

Read MSF's response to the World Health Organisation statement declaring the Ebola outbreak "an extraordinary event".


Nigeria's President Declares State of Emergency Over Ebola Threat - August 9, 2014

ABUJA, Aug. 7 (Xinhua) -- President Goodluck Jonathan declares a national emergency in a statement on Friday, saying 1.9 billion naira (11.6 million U.S. dollars) will be released to prevent further spread of the Ebola Virus.

He also urged Nigerians to desist from spreading rumors about the virus and advised school owners across the country to consider extending the current holiday.

He directed relevant government agencies to ensure that all possible steps are taken to effectively contain the threat of the Ebola virus in line with international protocols and best practices.


Ebola: Official MSF Response to WHO Declaring Epidemic an "Extraordinary Event"

    - August 8, 2014

In a statement released today, the World Health Organization (WHO) declared that West Africa's Ebola epidemic is an "extraordinary event" and now constitutes an international health risk.

"A coordinated international response is deemed essential to stop and reverse the international spread of Ebola," the WHO said in a statement after a two-day meeting of its emergency committee on Ebola.

MSF reaction to WHO Ebola statement

In response, Dr Bart Janssens, Médecins Sans Frontières/Doctors Without Borders (MSF) Director of Operations said:

“Declaring Ebola an international public health emergency shows how seriously WHO is taking the current outbreak but statements won’t save lives

“Now we need this statement to translate into immediate action on the ground. For weeks, MSF has been repeating that a massive medical, epidemiological and public health response is desperately needed to saves lives and reverse the course of the epidemic.

“Lives are being lost because the response is too slow.

WHO - List of Members of, and Advisers to, the International Health Regulations (2005) Emergency Committee Regarding Ebola - 6 and 7 August 2014


Dr Sam Zaramba

Senior Consultant Surgeon, Former Director General of Health Services, Ministry of Health, Kampala, Uganda


Professor Robert Steffen

Department of Epidemiology and Prevention of Infectious Diseases, WHO Collaborating Centre for Travellers’ Health, University of Zurich, Zurich, Switzerland

General Topic Tags: 
Problem, Solution, SitRep, or ?: 

CSPAN - House Foreign Affairs Subcommittee - Ebola Virus - August 7, 2014

The House Foreign Affairs Subcommittee on Africa, Global Health, Global Human Rights, and International Organizations held a hearing titled, “Combating the Ebola Threat.”

ZMapp - Information Sheet


ZMapp TM is the result of a collaboration between Mapp Biopharmaceutical Inc. and LeafBio (San Diego, CA), Defyrus Inc. (Toronto, Canada), the U.S. government and the Public Health Agency of Canada (PHAC).

ZMapp TM is composed of three “humanized” monoclonal antibodies manufactured in plants, specifically Nicotiana.  It is an optimized cocktail combining the best components of MB-­‐003 (Mapp) and ZMAb (Defyrus/PHAC).

ZMapp TM was first identified as a drug candidate in January 2014 and has not yet been evaluated for safety in humans.  As such very little of the drug is currently available.  

Any decision to use an experimental drug in a patient would be a decision made by the treating physician under the regulatory guidelines of the FDA.

Mapp and its partners are cooperating with appropriate government agencies to increase production as quickly as possible.

CLICK HERE - ZMapp - Information Sheet (1 page .PDF file)

Experimental Ebola Serum Grown in Tobacco Leaves

                                              - by Brenda Goodman - reviewed by Michael W. Smith, MD

Aug. 4, 2014 -- ZMapp, the experimental treatment rushed to two Americans infected with Ebola in Africa, is grown in specially modified leaves of tobacco -- a plant better known for harming health than healing.

“We complied with a request from Emory University and Samaritan’s Purse to provide a very limited amount of ZMapp last week,” says David Howard, a spokesman for Reynolds American Services, the parent company of Kentucky BioProcessing. The small biopharma company in Owensboro, KY, has been contracted to grow the drug.


Q & A - What You Need to Know About the Ebola Outbreak

Where is the Outbreak?


Source: United Nations Office for the Coordination of Humanitarian Affairs - by Joe Burgess, Denise Grady, Josh Keller, Heather Murphy and Sergio Peçanha - August 6, 2014

What are the chances of getting Ebola in the United States?

Two American aid workers infected with the Ebola virus while working in West Africa are being treated at a hospital in Atlanta, in a containment unit for patients with dangerous infectious diseases. But the risk that anyone will contract Ebola in the United States is extremely small, experts say.

Doctors across the country are being reminded to ask for the travel history of anybody who comes in with a fever.



Subscribe to Health
howdy folks